AU2752892A - Fusion proteins targeted to lysosomes, for the treatment of aids - Google Patents
Fusion proteins targeted to lysosomes, for the treatment of aidsInfo
- Publication number
- AU2752892A AU2752892A AU27528/92A AU2752892A AU2752892A AU 2752892 A AU2752892 A AU 2752892A AU 27528/92 A AU27528/92 A AU 27528/92A AU 2752892 A AU2752892 A AU 2752892A AU 2752892 A AU2752892 A AU 2752892A
- Authority
- AU
- Australia
- Prior art keywords
- lysosomes
- aids
- treatment
- fusion proteins
- proteins targeted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01049—Alpha-N-acetylgalactosaminidase (3.2.1.49)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70514—CD4
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6478—Aspartic endopeptidases (3.4.23)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01055—Alpha-N-arabinofuranosidase (3.2.1.55)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/06—Fusion polypeptide containing a localisation/targetting motif containing a lysosomal/endosomal localisation signal
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/32—Fusion polypeptide fusions with soluble part of a cell surface receptor, "decoy receptors"
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76696391A | 1991-09-26 | 1991-09-26 | |
US766963 | 1991-09-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2752892A true AU2752892A (en) | 1993-04-27 |
Family
ID=25078068
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU27528/92A Abandoned AU2752892A (en) | 1991-09-26 | 1992-09-22 | Fusion proteins targeted to lysosomes, for the treatment of aids |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2752892A (en) |
WO (1) | WO1993006216A1 (en) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5633234A (en) * | 1993-01-22 | 1997-05-27 | The Johns Hopkins University | Lysosomal targeting of immunogens |
US6987096B1 (en) | 1995-04-27 | 2006-01-17 | The United States Of America As Represented By The Department Of Health And Human Services | Antiviral proteins and peptides, DNA coding sequences therefor, and uses thereof |
US5962668A (en) * | 1995-04-27 | 1999-10-05 | The United States Of America As Represented By The Department Of Health And Human Services | Nucleic acids encoding antiviral proteins and peptides fused to effector proteins |
US6780847B2 (en) | 1995-04-27 | 2004-08-24 | The United States Of America As Represented By The Department Of Health And Human Services | Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins |
US7048935B2 (en) | 1995-04-27 | 2006-05-23 | The United States Of America As Represented By The Department Of Health And Human Services | Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use |
US6428790B1 (en) | 1995-04-27 | 2002-08-06 | The United States Of America As Represented By The Secretary Department Of Health And Human Services | Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use |
US6193982B1 (en) | 1995-04-27 | 2001-02-27 | The United States Of America As Represented By The Department Of Health & Human Services | Anti-cyanovirin antibody with an internal image of gp120, a method of use thereof, and a method of using a cyanovirin to induce an immune response to gp120 |
US5843882A (en) * | 1995-04-27 | 1998-12-01 | The United States Of America As Represented By The Department Of Health And Human Services | Antiviral proteins and peptides |
US6348194B1 (en) * | 1995-11-13 | 2002-02-19 | Ixsys Incorporated | Tumor specific internalizing antigens and methods for targeting therapeutic agents |
US6316210B1 (en) | 1995-12-20 | 2001-11-13 | Subsidiary No. 3, Inc. | Genetic suppressor elements against human immunodeficiency virus |
US6537972B1 (en) | 1997-06-02 | 2003-03-25 | Subsidiary No. 3., Inc. | Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
US6071743A (en) | 1997-06-02 | 2000-06-06 | Subsidiary No. 3, Inc. | Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
US6613506B1 (en) | 2000-11-28 | 2003-09-02 | Subsidiary No. 3, Inc. | Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
AU2352201A (en) * | 1999-12-30 | 2001-07-16 | Maxygen Aps | Improved lysosomal enzymes and lysosomal enzyme activators |
JP4307841B2 (en) | 2001-03-22 | 2009-08-05 | アメリカ合衆国 | Glycosylation resistant cyanovirin and related conjugates, compositions, nucleic acids, vectors, host cells, methods of making and using non-glycosylated cyanovirins |
US7560424B2 (en) | 2001-04-30 | 2009-07-14 | Zystor Therapeutics, Inc. | Targeted therapeutic proteins |
IL158623A0 (en) | 2001-04-30 | 2004-05-12 | Symbiontics Inc | Subcellular targeting of therapeutic proteins |
US7629309B2 (en) | 2002-05-29 | 2009-12-08 | Zystor Therapeutics, Inc. | Targeted therapeutic proteins |
US20030072761A1 (en) | 2001-10-16 | 2003-04-17 | Lebowitz Jonathan | Methods and compositions for targeting proteins across the blood brain barrier |
CA2484719A1 (en) | 2002-05-16 | 2003-11-27 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies, and methods of using scytovirins |
US20050244400A1 (en) | 2004-02-10 | 2005-11-03 | Zystor Therapeutics, Inc. | Acid alpha-glucosidase and fragments thereof |
HUE034850T2 (en) | 2008-05-07 | 2018-03-28 | Biomarin Pharm Inc | Lysosomal targeting peptides and uses thereof |
CN108779161A (en) * | 2015-09-22 | 2018-11-09 | 宾夕法尼亚大学董事会 | Redirect method of the T cell to treat HIV infection |
CN113301925A (en) | 2018-12-19 | 2021-08-24 | 小利兰·斯坦福大学理事会 | Bifunctional molecules for lysosomal targeting and related compositions and methods |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990004414A1 (en) * | 1988-10-18 | 1990-05-03 | Biogen, Inc. | Conjugates of soluble t4 proteins and toxins and methods for treating or preventing aids, arc and hiv infection |
-
1992
- 1992-09-22 AU AU27528/92A patent/AU2752892A/en not_active Abandoned
- 1992-09-22 WO PCT/US1992/008090 patent/WO1993006216A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1993006216A1 (en) | 1993-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2752892A (en) | Fusion proteins targeted to lysosomes, for the treatment of aids | |
AU7122291A (en) | 3-arylcarbonyl-1h-indoles useful as therapeutic agents | |
AU1293592A (en) | Biomedical electrode construction | |
AU4780596A (en) | Hemi-wheeled walker | |
AU7034796A (en) | Short leg walker | |
ZA968957B (en) | Process for the preparation of dihaloazolopyrimidines. | |
MX20359A (en) | DERIVATIVES OF 2-OXINDOL 3-SUBSTITUTED. | |
AU7867994A (en) | Hemofiltration of mediator-related diseases | |
HK1066010A1 (en) | Optically active compounds which are useful as intermediates in the preparation of optically acitve-2-imidazoline-5-thione derivatives | |
AU1597795A (en) | Method of enhancing the human immune system | |
AU4209197A (en) | Process for the control of weeds | |
HK1011024A1 (en) | Phosphorus derivatives to treat aids. | |
AUPP105497A0 (en) | Aqueous insecticidal pour-on treatment | |
AU7120991A (en) | Optically active 8-methoxyquinolonecarboxylic acid derivatives, their preparative processes and their intermediates | |
AU4208897A (en) | Oligocistronic expression system for the production of heteromeric proteins | |
ITMI940317A0 (en) | PROCEDURE FOR THE PRODUCTION OF GAMMA-BUTYROLACTONE | |
AU2285492A (en) | Improved cultivator | |
AU2473295A (en) | An improved ocular care solution | |
AU3731595A (en) | Improved process for the preparation of 5-aminotetrazole | |
HUP9900739A3 (en) | Process for the preparation of quinoline derivatives, and the intermediates | |
AUPM963094A0 (en) | Cultivator | |
HUP0000807A3 (en) | Process for the preparation of optically active n-benzyl-3-pyrrolidinol | |
ZA966452B (en) | Process for the preparation of substituted aminocarbonyltriazolinones. | |
AU2754997A (en) | The treatment of plant diseases | |
AU2838397A (en) | Process for the preparation of optically active amines |